TEL AVIV, Israel & PARSIPPANY, N.J.--(BUSINESS WIRE)-- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced 12 presentations across its ...
The Gyrolab ® AAV9 Titer Kit was designed to allow researchers to improve productivity. The kit is based on an AAV9 affinity ligand developed with the Thermo Scientificâ„¢ CaptureSelectâ„¢ technology by ...